Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Insulet lowered its annual sales growth forecast on Wednesday, pointing to a softer second half of 2026 particularly for U.S. sales ​of its Omnipod insulin pumps, sending shares of the company ‌down m...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。